Capital expenditure increased 274.6%
Capital expenditure changed +274.6% from the comparable as-filed period.
$142.0M→$532.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AVGO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash / debt moved 2329 bp higher
Cash / debt changed +2329 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
17.06%→40.35%4 prior comparisons
Working capital / assets moved 1165 bp higher
Working capital / assets changed +1165 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
5.01%→16.65%4 prior comparisons
Debt / assets moved 636 bp lower
Debt / assets changed -636 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
37.94%→31.58%4 prior comparisons
Current liabilities increased 24.7%
Current liabilities changed +24.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$16.7B→$20.8B4 prior comparisons
Debt / revenue moved 19307 bp lower
Debt / revenue changed -19307 basis points from the comparable as-filed period.
393.87%→200.80%2 prior comparisons
Receivables / revenue moved 561 bp higher
Receivables / revenue changed +561 basis points from the comparable as-filed period.
40.71%→46.32%2 prior comparisons
R&D / revenue moved 934 bp lower
R&D / revenue changed -934 basis points from the comparable as-filed period.
19.12%→9.78%2 prior comparisons
Operating cash-flow margin moved 306 bp higher
Operating cash-flow margin changed +306 basis points from the comparable as-filed period.
44.92%→47.98%2 prior comparisons
Total assets increased 13.6%
Total assets changed +13.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$165.6B→$188.1B4 prior comparisons
Capex / revenue moved 91 bp higher
Capex / revenue changed +91 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.89%→1.80%2 prior comparisons
Inventory / revenue moved 162 bp higher
Inventory / revenue changed +162 basis points from the comparable as-filed period.
13.67%→15.29%2 prior comparisons
Stock-based compensation decreased 13.0%
Stock-based compensation changed -13.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.3B→$2.0B2 prior comparisons
Free-cash-flow margin moved 215 bp higher
Free-cash-flow margin changed +215 basis points from the comparable as-filed period.
44.03%→46.18%2 prior comparisons
Research & development decreased 5.1%
Research & development changed -5.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$3.1B→$2.9B2 prior comparisons
Shares outstanding increased 1.1%
Shares outstanding changed +1.1% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
4,722,365,022→4,773,629,8658 prior comparisons
Reported total debt decreased 5.4%
Reported total debt changed -5.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$62.8B→$59.4B4 prior comparisons
Gross debt decreased 5.4%
Gross debt changed -5.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$62.8B→$59.4B4 prior comparisons
Selling, general & administrative decreased 7.1%
Selling, general & administrative changed -7.1% from the comparable as-filed period.
$1.1B→$996.0M2 prior comparisons
SBC / revenue moved 237 bp lower
SBC / revenue changed -237 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
11.80%→9.43%2 prior comparisons
Gross margin moved 152 bp higher
Gross margin changed +152 basis points from the comparable as-filed period.
67.96%→69.48%2 prior comparisons
Capital expenditure increased 60.4%
Capital expenditure changed +60.4% from the comparable as-filed period.
$144.0M→$231.0M3 prior comparisons
Cash / debt moved 1490 bp higher
Cash / debt changed +1490 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
15.34%→30.24%4 prior comparisons
Working capital / assets moved 1207 bp higher
Working capital / assets changed +1207 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
0.96%→13.03%4 prior comparisons
Receivables / revenue moved 1174 bp higher
Receivables / revenue changed +1174 basis points from the comparable as-filed period.
37.08%→48.81%2 prior comparisons
R&D / revenue moved 445 bp lower
R&D / revenue changed -445 basis points from the comparable as-filed period.
17.95%→13.50%2 prior comparisons
Debt / revenue moved 11902 bp lower
Debt / revenue changed -11902 basis points from the comparable as-filed period.
411.56%→292.55%2 prior comparisons
Free-cash-flow margin moved 352 bp higher
Free-cash-flow margin changed +352 basis points from the comparable as-filed period.
42.73%→46.25%2 prior comparisons
Operating cash-flow margin moved 361 bp higher
Operating cash-flow margin changed +361 basis points from the comparable as-filed period.
43.69%→47.29%2 prior comparisons
Stock-based compensation increased 18.1%
Stock-based compensation changed +18.1% from the comparable as-filed period.
$1.8B→$2.1B2 prior comparisons
Research & development increased 11.2%
Research & development changed +11.2% from the comparable as-filed period.
$2.7B→$3.0B2 prior comparisons
Total assets increased 8.8%
Total assets changed +8.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$164.6B→$179.2B4 prior comparisons
Net debt decreased 13.4%
Net debt changed -13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$52.3B→$45.3B4 prior comparisons
Capex / revenue moved 8 bp higher
Capex / revenue changed +8 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.96%→1.04%2 prior comparisons
Reported total debt increased 5.1%
Reported total debt changed +5.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$61.8B→$64.9B4 prior comparisons
Gross debt increased 5.1%
Gross debt changed +5.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$61.8B→$64.9B4 prior comparisons
Shares outstanding increased 1.2%
Shares outstanding changed +1.2% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
4,703,470,979→4,757,580,1988 prior comparisons
Current liabilities decreased 8.4%
Current liabilities changed -8.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$20.6B→$18.9B4 prior comparisons
Debt / assets moved 128 bp lower
Debt / assets changed -128 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
37.51%→36.23%4 prior comparisons
Selling, general & administrative decreased 2.6%
Selling, general & administrative changed -2.6% from the comparable as-filed period.
$1.1B→$1.1B2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.